Pharmacological treatment of PTSD - Established and new approaches

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 617-627

  Steckler, Thomas ^a   Risbrough, Victoria ^b,c  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Consolidation; Extinction; Fear conditioning; Glucocorticoid; Glutamate; Prevention; PTSD; Review; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; ANANDAMIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CANNABINOID; CYCLOSERINE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MIDAZOLAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; PRAZOSIN; PROPRANOLOL; RISPERIDONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; BODY WEIGHT; CHRONIC STRESS; COGNITIVE DEFECT; CONDITIONING; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; MEMORY CONSOLIDATION; NEUROMODULATION; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SECONDARY PREVENTION; SEXUAL DYSFUNCTION; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; RECEPTORS, GLUCOCORTICOID; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84855935833     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.06.012     Document Type: Review

References (174)

1. D.T. Acheson, J.E. Gresack, and V.B. Risbrough Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder Neuropharmacology 62 2011 647 685
2. R.E. Adamec, T. Shallow, and J. Budgell Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder Behav. Neurosci. 111 1997 435 449
3. R.E. Adamec, P. Burton, T. Shallow, and J. Budgell NMDA receptors mediate lasting increases in anxiety-like behaviour produced by the stress of predator exposure - implications for anxiety associated with posttraumatic stress disorder Physiol. Behav. 65 1999 723 737
4. R. Adamec, D. Fougere, and V. Risbrough CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD Int. J. Neuropsychopharm. 13 2010 747 757
5. R. Adamec Transmitter systems involved in neural plasticity underlying increased anxiety and defense - implications for understanding anxiety following anxiety following traumatic stress Neurosci. Biobehav Rev. 21 1997 755 765
6. M. Adamou, S. Puchalska, W. Plummer, and A.S. Hale Valproate in the treatment of PTSD: systematic review and meta analysis Curr. Med. Res. Opin. 23 2007 1285 1291
7. A. Aerni, R. Traber, C. Hock, B. Roozendaal, G. Schelling, A. Papassotiropoulos, R.M. Nitsch, U. Schnyder, and D.J. de Quervain Low-dose cortisol for symptoms of posttraumatic stress disorder Am. J. Psychiat. 161 2004 1488 1490
8. S. Ahmad, L. Fowler, and P.S. Whitton Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats Brain Res. 1029 2004 41 47
9. T. Amano, C.T. Unal, and D. Pare Synaptic correlates of fear extinction in the amygdala Nat. Neurosci. 13 2010 489 495
10. A. Arnsten, J. Cai, and P. Goldman-Rakic The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes J. Neurosci. 8 11 1988 4287 4298
11. R.L. Aupperle, A.J. Melrose, M.B. Stein, and M.P. Paulus Executive function and PTSD: disengaging from trauma Neuropharmacology 62 2011 686 694
12. D.G. Baker, S.A. West, W.E. Nicholson, N.N. Ekhator, J.W. Kasckow, K.K. Hill, A.B. Bruce, D.N. Orth, and T.D. Geracioti Jr. Serial CSF corticotrophin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder Am. J. Psychiatry 156 1999 585 588
13. D.G. Baker, N.N. Ekhator, J.W. Kasckow, B. Dashevsky, P.S. Horn, L. Bednarik, and T.D. Geracioti Jr. Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder Am. J. Psychiatry 162 2005 992 994
14. D.G. Baker, C.M. Nievergelt, and V.B. Risbrough Post-traumatic stress disorder: emerging concepts of pharmacotherapy Expert Opin. Emerg. Drugs 14 2 2009 251 272
15. B. Bandelow, J. Zohar, E. Hollander, S. Kasper, H.J. Moller, J. Zohar, E. Hollander, S. Kasper, H.J. Moller, B. Bandelow, C. Allgulander, J. Ayuso-Gutierrez, D.S. Baldwin, R. Buenvicius, G. Cassano, N. Fineberg, L. Gabriels, I. Hindmarch, H. Kaiya, D.F. Klein, M. Lader, Y. Lecrubier, J.P. Lepine, M.R. Liebowitz, J.J. Lopez-Ibor, D. Marazziti, E.C. Miguel, K.S. Oh, M. Preter, R. Rupprecht, M. Sato, V. Starcevic, D.J. Stein, M. van Ameringen, J. Vega WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disoders World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision World J. Biol. Psychiatry 9 2008 248 312
16. D.M. Benedek, M.J. Fiedman, D. Zatzick, and R.J. Ursano Guideline watch (March 2009): practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder J. Lifelong Learn. 7 2009 204 213
17. W. Berger, M.V. Mendlowicz, C. Marques-Portella, G. Kinrys, L.F. Fontenelle, C.R. Marmar, and I. Figueira Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review Prog. Neuropsychopharmacol. Biol. Psychiat. 33 2009 169 180
18. H.A. Berlin Antiepileptic drugs for the treatment of post-traumatic stress disorder Curr. Psychiat. Rep. 9 2007 291 300
19. E.B. Binder, R.G. Bradley, W. Liu, M.P. Epstein, T.C. Deveau, K.B. Mercer, Y. Tang, C.F. Gillespie, C.M. Heim, C.B. Nemeroff, A.C. Schwartz, J.F. Cubells, and K.J. Ressler Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults JAMA 299 2008 1291 1305
20. J. Blechert, T. Michael, N. Vriends, J. Markgraf, and F.H. Wilhelm Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experimental, and behavioural responses Behav. Res. Ther. 45 2007 2019 2033
21. J. Blundell, M. Kouser, and C.M. Powell Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation Neurobiol. Learn. Mem. 90 2008 28 35
22. K. Brady, T. Pearlstein, G.M. Asnis, D. Baker, B. Rothbaum, C.R. Sikes, and G.M. Farfel Efficacy and safety of sertaline treatment of posttraumatic stress disorder: a randomized controlled trial JAMA 283 2000 1837 1844
23. P. Braun, D. Greenberg, H. Dasberg, and B. Lerer Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment J. Clin. Psychiat. 51 1990 236 238
24. J.D. Bremner, J. Licinio, A. Darnell, J.H. Krystall, M.J. Owens, S.M. Soutwick, C.B. Nemeroff, and D.S. Charney Elevated CSF corticotrophin-releasing factor concentrations in posttraumatic stress disorder Am. J. Psychiatry 154 1997 624 629
25. A. Brunet, S.P. Orr, J. Tremblay, K. Robertson, K. Nader, and R.K. Pitman Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder J. Psychiat. Res. 42 2008 503 506
26. R.A. Bryant, M. Cremer, M. O'Donnell, D. Silove, and A.C. McFarlane A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder Biol. Psychiat. 65 2009 438 440
27. S.G. Bustos, H. Maldonado, and V.A. Molina Midazolam disrupts fear memory reconsolidation Neuroscience 139 2006 831 842
28. M.I. Butterfield, M.E. Becker, K.M. Connor, S. Sutherland, L.E. Churchill, and J.R. Davidson Olanzapine in the treatment of post-traumatic stress disorder: a pilot study Int. Clin. Psychopharmacol. 16 2001 197 203
29. M.G. Byers, K.M. Allison, C.S. Wendel, and J.K. Lee Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety J. Clin. Psychopharmacol. 30 3 2010 225 229
30. L. Cahill, J. Brioni, and I. Izquierdo Retrograde memory enhancement by diazepam: its relation to anterograde amnesia, and some clinical implications Psychopharmacology 90 1986 554 556
31. C.K. Cain, A.M. Blouin, and M. Barad Adrenergic transmission facilitates extinction of conditional fear in mice Learn. Mem. 11 2004 179 187
32. M.E. Cates, M.H. Bishop, L.L. Davis, J.S. Lowe, and T.W. Woolley Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder Ann. Pharmacother. 38 2004 1395 1399
33. D.S. Charney Psychological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress Am. J. Psychiat. 161 2004 195 216
34. J.P. Chhatwal, M. Davis, K.A. Maguschak, and K.J. Ressler Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear Neuropsychopharmacology 30 2005 516 524
35. H. Cohen, Z. Kaplan, M.A. Matar, U. Loewenthal, N. Kozlovsky, and J. Zohar Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress responses in rats Biol. Psychiat. 60 2006 767 776
36. H. Cohen, M.A. Matar, D. Buskila, Z. Kaplan, and J. Zohar Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress responses in an animal model of posttraumatic stress disorder Biol. Psychiat. 64 2008 708 717
37. Committee on Treatment of Posttraumatic Stress Disorder Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence 2008 National Academies Press Washington DC, USA
38. K.M. Connor, S.M. Sutherland, L.A. Tupler, M.K. Malik, and J.R. Davidson Fluoxetine in posttraumatic stress disorder. Randomised, double-blind study Br. J. Psychiatry 175 1999 17 22
39. J. Davidson, H. Kudler, R. Smith, S.L. Mahorney, S. Lipper, E. Hammett, W.B. Saunders, and J.O. Cavenar Jr. Treatment of posttraumatic stress disorder with amitryptiline and placebo Arch. Gen Psychiat. 58 1990 485 492
40. J.R. Davidson, R.H. Weisler, M.I. Butterfield, C.D. Casat, K.M. Connor, S. Barnett, and S. Van Meter Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial Biol. Psychiatry 53 2003 188 191
41. J. Davidson, B.O. Rothbaum, P. Tucker, G. Asnis, I. Benattia, and J.J. Musgnung Venlafaxine extended release in posttraumatic stress disorder: a sertaline and placebo-controlled study J. Clin. Psychopharmacol. 26 2006 259 267
42. M.F. Davies, J. Tsui, J.A. Flannery, X. Li, T.M. DeLorey, and B.B. Hoffman Activation of alpha2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala Neuropsychopharmacology 29 2004 229 239
43. L.L. Davis, C. Ward, A. Rasmusson, J.M. Newell, E. Frazier, and S.M. Southwick A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans Psychopharmacol. Bull. 41 2008 8 18
44. L. De Oliveira Alvares, B. Pasqualini Genro, F. Diehl, V.A. Molina, and J.A. Quillfeldt Oposite action of hippocampal CB1 receptors in memory reconsolidation and extinction Neuroscience 154 2008 1648 1655
45. D.J. De Quervain, B. Roozendaal, and J.L. McGaugh Stress and glucocorticoids impair retrieval of long-term spatial memory Nature 394 1998 787 790
46. D.J. De Quervain, A. Aerni, and B. Roozendaal Preventive effect of ß-adrenoceptor blockade on glucocorticoid-induced memory retrieval deficits Am. J. Psychiatry 164 2007 967 969
47. D.J. De Quervain, A. Aerni, G. Schelling, and B. Roozendaal Glucocorticoids and the regulation of memory in health and disease Front. Neuroendocrinol. 30 2009 358 370
48. J. Debiec, and J.E. Ledoux Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala Neuroscience 129 2 2004 267 272
49. A. Del Arco, and F. Mora Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders J. Neural Transm. 116 2009 941 952
50. A.J. Dunn, A.H. Swiergiel, and V. Palamarchouk Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress Ann. NY Acad. Sci. 1018 1 2004 25 34
51. A. Ettenberg, M. Le Moal, G.F. Koob, and F.E. Bloom Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin Pharmacol. Biochem. Behav. 18 1982 645 647
52. W.A. Falls, M.J. Miserendino, and M. Davis Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala J. Neurosci. 12 1992 854 863
53. M. Fendt, and S. Schmid Metabotropic glutamate receptors are involved in amygdaloid plasticity Eur. J. Neurosci. 15 2002 1535 1541
54. S. Fletcher, M. Creamer, and D. Forbes Preventing post traumatic stress disorder: are drugs the answer? Aust. N. Z. J. Psychiatry 44 12 2010 1064 1071
55. J.B. Frank, T.R. Kosten, E.L. Giller Jr., and E. Dan A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder Am. J. Psychiatry 145 1988 1289 1291
56. J.T. Gass, and M.F. Olive Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory Biol. Psychiat. 65 2009 717 720
57. E. Gelpin, O. Bonne, T. Peri, D. Brandes, and A.Y. Shalev Treatment of recent trauma survivors with benzodiazepines: a prospective study J. Clin. Psychiat. 57 1996 390 394
58. G.M. Gilad, V.H. Gilad, R.J. Wyatt, and Y. Tizabi Region-selective stress-induced increase of glutamate uptake and release in rat forebrain Brain Res. 525 1990 335 338
59. P.W. Gold, J. Licinio, M.L. Wong, and G.P. Chrousos Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs Ann. NY Acad. Sci. USA 771 1995 716 729
60. H.J. Grabe, C. Spitzer, C. Schwahn, A. Marcinek, A. Frahnow, S. Barnow, M. Lucht, H.J. Freyberger, U. John, H. Wallaschofski, H. Völzke, and D. Rosskopf Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population Am. J. Psychiatry 166 2009 926 933
61. J.E. Gresack, and V.B. Risbrough Corticotropin-releasing factor and noradrenergic signaling exert reciprocal control over startle reactivity Int. J. Neuropsychopharmacol. 2010 1 16 Epub of preprint
62. C. Grillon, S.M. Southwick, and D.S. Charney The psychobiological basis of posttraumatic stress disorder Mol. Psychiat. 1 1996 278 297
63. C. Grillon d-Cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms Biol. Psychiatry 66 7 2009 636 641
64. A.J. Guastella, P.F. Lovibond, M.R. Dadds, P. Mitchell, and R. Richardson A randomized controlled trial of the effect of d-cycloserine on extinction and fear conditioning in humans Behav. Res. Ther. 45 4 2007 663 672
65. A.J. Guastella, R. Richardson, P.F. Lovibond, R.M. Rapee, J.E. Gaston, P. Mitchell, and M.R. Dadds A randomized controlled trial of d-cycloserine enhancement of exposure therapy for social anxiety disorder Biol. Psychiat. 63 2008 544 549
66. R.M. Guthrie, and R.A. Bryant Extinction learning before trauma and subsequent posttraumatic stress Psychosom. Med. 68 2006 307 311
67. N. Haddjeri, P. Blier, and C. De Montigny Effect of the α2-adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain J. Pharmacol. Exp. Ther. 277 1996 861 871
68. I. Hageman, H.S. Andersen, and M.B. Jørgensen Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy Acta Psych Scand. 104 2001 411 422
69. M.B. Hamner, R.A. Faldowski, H.G. Ulmer, B.C. Frueh, M.G. Huber, and G.W. Arana Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms Int. Clin. Psychopharmacol. 18 2003 1 8
70. T.L. Holbrook, M.R. Galarneau, K. Quinn, and A.L. Dougherty Morphine use after combat injury in Iraq and post-traumatic stress disorder. New Engl J Med 362 2010 110 117
71. J.V. Hinrichs, M.M. Ghoneim, and S.P. Mewaldt Diazepam and memory: retrograde facilitation produced by interference reduction Psychopharmacology 84 1984 158 162
72. E. Hollander, J. Bartz, W. Chaplin, A. Phillips, J. Sumner, and L. Soorya Oxytocin increases retention of social cognition in autism Biol. Psychiatry 61 4 2007 498 503
73. A. Holmes, and G.J. Quirk Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders - the case of yohimbine Trends Pharmacol. Sci. 31 2010 2 7
74. D.T. Hubbard, B.R. Nakashima, I. Lee, and L.K. Takahashi Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear Neuroscience 150 4 2007 818
75. R. Hurlemann, A. Matusch, D. Klingmuller, B. Hawellek, H. Kolsch, W. Maier, and R.J. Dolan Emotion-induced retrograde amnesia varies as a function of noradrenergic-glucocorticoid activity Psychopharmacology 194 2007 261 269
76. R. Hurlemann Noradrenergic-glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease Psychopharmacology 197 2008 13 23
77. R.A. Jensen, J.L. Martinez Jr., B.J. Vasquez, and J.L. McGaugh Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice Psychopharmacology (Berl) 64 1 1979 125 126
78. D.M. Johnson, J.D. Baker, and J.L. Azorlosa Acquisition, extinction, and reinstatement of Pavlovian fear conditioning: the roles of the NMDA receptor and nitric oxide Brain Res. 857 2000 66 70
79. S. Kasper, and B.S. McEwen Neurobiological and clinical effects of the antidepressant tianeptine CNS Drugs 22 2008 15 26
80. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 62 2005 593 602
81. S. Khan, and I. Liberzon Topiramate attenuates exaggerated acoustic startle in an animal model of PTSD Psychopharmacology 172 2004 225 229
82. D. Knox, S.A. Perrine, S.A. George, M.P. Galloway, and I. Liberzon Single prolonged stress decreases glutamate, glutamine, and creatine concentrations in the rat medial prefrontal cortex Neurosci. Lett. 480 2010 16 20
83. M. Koenigs, and J. Grafman Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdala Neuroscientist 15 2009 540 548
84. K. Kohda, K. Harada, K. Kato, A. Hoshino, J. Motohashi, T. Yamaji, S. Morinobu, N. Matsuoka, and N. Kato Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model Neuroscience 148 2007 22 33
85. J.H. Krystal, and A. Neumeister Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience Brain Res. 1293 2009 13 23
86. K.M. Lattal, R.M. Barrett, and M.A. Wood Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction Behav. Neurosci. 121 2007 1125 1131
87. L. Ledgerwood, R. Richardson, and J. Cranney Effects of d-cycloserine on extinction of conditioned freezing Behav. Neurosci. 117 2003 341 349
88. H.J. Lee, M.S. Lee, R.H. Kang, H. Kim, S.D. Kim, B.S. Kee, Y.H. Kim, Y.K. Kim, J.B. Kim, B.K. Yeon, K.S. Oh, B.H. Oh, J.S. Yoon, C. Lee, H.Y. Jung, I.S. Chee, and I.H. Paik Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder Depr Anx 21 2005 135 139
89. J.L. Lee, A.L. Milton, and B.J. Everitt Reconsolidation and extinction of conditioned fear: inhibition and potentiation J. Neurosci. 26 2006 10051 10056
90. A.C. Leon, and L.L. Davis Enhancing clinical trial design of interventions for posttraumatic stress disorder J. Traumatic Stress 22 6 2009 603 611
91. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, M. Iwata, X.Y. Li, G. Aghajanian, and R.S. Duman mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
92. I. Liberzon, S. Khan, and E.A. Young Animal models of posttraumatic stress disorder T. Steckler, N.H. Kalin, J.M.H.M. Reul, Handbook of Stress and the Brain, part 2 2005 Elsevier Amsterdam 231 250
93. E. Likhtik, D. Popa, J. Apergis-Schoute, G.A. Fidacaro, and D. Pare Amygdala intercalated neurons are required for expression of fear extinction Nature 454 2008 642 645
94. H.C. Lin, S.C. Mao, and P.W. Gean Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle Learn. Mem. 13 2006 316 321
95. H.C. Lin, S.C. Mao, P.S. Chen, and P.W. Gean Chronic cannabinoid administration in vivo compromises extinction of fear memory Learn. Mem. 15 2008 876 884
96. A.C.E. Linthorst Stress, corticotrophin-releasing factor and serotonergic neurotransmission T. Steckler, N.H. Kalin, J.M.H.M. Reul, Handbook of Stress and the Brain, Part 1 2005 Elsevier Amsterdam 503 524
97. S.C. Mao, H.C. Lin, and P.W. Gean Augmentation of fear extinction by infusion of glycine transporter blockers into the amygdala Mol. Pharmacol. 76 2 2009 369 378
98. F. Martenyi, E.B. Brown, H. Zhang, S.C. Koke, and A. Prakash Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder Br. J. Psychiatry 181 2002 315 320
99. M.A. Matar, J. Zohar, Z. Kaplan, and H. Cohen Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD Eur. Neuropsychopharm. 19 2009 283 295
100. G.K. Matheson, A. Knowles, D. Guthrie, D. Gage, D. Weinzapfel, and J. Blackbourne Actions of serotonergic agents on hypothalamic-pituitary-adrenal axis activity in the rat Gen. Pharmacol. 29 1997 823 828
101. B.S. McEwen, S. Chattarji, D.M. Diamond, T.M. Jay, L.P. Reagan, P. Svenningsson, and E. Fuchs The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation Mol. Psychiat. 15 2010 237 249
102. L.L. McGhee, C.V. Maani, T.H. Garza, K.M. Gaylord, and I.H. Black The correlation between ketamine and posttraumatic stress disorder in burned service members J. Trauma Injur Inf. Crit. Care 64 Suppl. 2 2008 S195 S198
103. A.L. McRae, K.T. Brady, T.A. Mellman, S.C. Sonne, T.K. Killeen, M.A. Timmerman, and W. Bayles-Dazet Comparison of nefazodone and sertaline for the treatment of posttraumatic stress disorder Depr. Anxiety 19 2004 190 196
104. D. Mehta, and E.B. Binder Gene × Environment vulnerability factors for PTSD: the HPA axis Neuropharmacology 62 2011 654 662
105. T.A. Mellman, V. Bustamante, D. David, and A.I. Fins Hypnotic medication in the aftermath of trauma J. Clin. Psychiat. 63 2002 1183 1184
106. E. Menegola, F. Di Renzo, M.L. Broccia, M. Prudenziati, S. Minucci, V. Massa, and E. Giavini Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity Birth Defects Res. (Part B) 74 2005 392 398
107. M.R. Milad, and S.L. Rauch The role of the orbitofrontal cortex in anxiety disorders Ann. NY Acad. Sci. 1121 2007 546 561
108. M.R. Milad, R.K. Pitman, C.B. Ellis, A.L. Gold, L.M. Shin, N.B. Lasko, M.A. Zeidan, K. Handwerger, S.P. Orr, and S.L. Rauch Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder Biol. Psychiat. 66 2009 1075 1082
109. B. Moghaddam, M.L. Bolinao, B. Stein-Behrens, and R. Sapolsky Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate Brain Res. 655 1994 251 254
110. B. Moghaddam Stress preferentially increases extraneuronal levels of amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia J. Neurochem. 60 1993 1650 1657
111. E.P. Monnelly, D.A. Ciraulo, C. Knapp, and T. Keane Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder J. Clin. Psychopharmacol. 23 2003 193 196
112. R.W. Morris, and M.E. Bouton The effect of yohimbine on the extinction of conditioned fear: a role for context Behav. Neurosci. 121 2007 501 514
113. D. Mueller, L.A. Olivera-Figueroa, D.S. Pine, and G.J. Quirk The effects of yohimbine and amphetamine on fear expression and extinction in rats Psychopharmacology 204 2009 599 606
114. E.V. Muravieva, and C.M. Alberini Limited efficacy of propranolol on the reconsolidation of fear memories Learn. Mem. 17 2010 306 313
115. K.M. Myers, W.A. Carlezon Jr., and M. Davis Glutamate receptors in extinction and extinction-based therapies for psychiatric illness Neuropsychopharmacol. Rev. 36 2011 274 293
116. J.W. Newcomer, G. Selke, A.K. Melson, T. Hershey, S. Craft, K. Richards, and A.L. Alderson Decreased memory performance in healthy humans induced by stress-level cortisol treatment Arch. Gen. Psychiat. 56 1999 527 533
117. T.C. Neylan, M. Lenoci, K.W. Samuelson, T.J. Metzler, C. Henn-Haase, R.W. Hierholzer, S.E. Lindley, C. Otte, F.B. Schoenfeld, J.A. Yesavage, and C.R. Marmar No improvement of posttraumatic stress disorder symptoms with guanfacine treatment Am. J. Psychiatry 163 2006 2186 2188
118. S.D. Norrholm, T. Jovanovic, I.W. Olin, L.A. Sands, I. Karapanou, and B. Bradley Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity Biol. Psychiat 69 2011 556 563
119. M.L. O'Donnell, M. Creamer, P. Elliott, and R. Bryant Tonic and phasic heart rate as predictors of posttraumatic stress disorder Psychosom. Med. 69 3 2007 256 261
120. E. Onder, U. Tural, and T. Aker A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake Eur. Psychiat. 21 2006 174 179
121. M.W. Otto, D.F. Tolin, N.M. Simon, G.D. Pearlson, S. Basden, S.A. Meunier, S.G. Hofmann, K. Eisenmenger, J.H. Krystal, and M.H. Pollack Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder Biol. Psychiat. 67 2010 365 370
122. K. Pacak, M. Palkovits, I.J. Kopin, and D.S. Goldstein Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympatho-adrenal activity: in vivo microdialysis studies Front. Neuroendocrinol 16 1995 89 150
123. P.R. Padala, J. Madison, M. Monnahan, W. Marcil, P. Price, S. Ramaswamy, A.U. Din, D.R. Wilson, and F. Petty Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women Int. Clin. Psychopharmacol. 21 2006 275 280
124. F.A. Pamplona, R.D. Prediger, P. Pandolfo, and R.N. Takahashi The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats Psychopharmacology 188 2006 641 649
125. E.R. Peskind, L.T. Bonner, D.J. Hoff, and M.A. Raskind Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder J. Geriat Psychiat. Neurol. 16 2003 165 171
126. A. Pitkänen, V. Savander, and J.E. LeDoux Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala Trends Neurosci. 20 1997 517 523
127. R.K. Pitman, and D.L. Delahanty Conceptually driven pharmacologic approaches to acute trauma CNS Spectrums 10 2005 99 106
128. R.K. Pitman, K.M. Sanders, R.M. Zusman, A.R. Healy, F. Cheema, N.B. Lasko, L. Cahill, and S.P. Orr Pilot study of secondary prevention of posttraumatic stress disorder with propranolol Biol. Psychiat. 51 2002 189 192
129. G.J. Quirk, and D. Mueller Neural mechanisms of extinction learning and retrieval Neuropsychopharmacology 33 2008 56 72
130. J.J. Radley, K.L. Gosselink, and P.E. Sawchenko A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response J. Neurosci. 29 2009 7330 7340
131. M.A. Raskind, E.R. Peskind, E.D. Kanter, E.C. Petrie, A. Radant, C.E. Thompson, D.J. Dobie, D. Hoff, R.J. Rein, K. Straits-Tröster, R.G. Thomas, and M.M. McFall Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study Am. J. Psychiat. 160 2003 371 373
132. M.A. Raskind, E.R. Peskind, D.J. Hoff, K.L. Hart, H.A. Holmes, D. Warren, J. Shofer, J. O'Connell, F. Taylor, C. Gross, K. Rohde, and M.E. McFall A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder Biol. Psychiatry 61 2007 928 934
133. L.N. Ravindran, and M.B. Stein Pharmacotherapy of post-traumatic stress disorder M.B. Stein, T. Steckler, Behavioral Neurobiology of Anxiety and Its Treatment 2010 Springer Heidelberg 505 525
134. D.B. Reich, S. Winternitz, J. Hennen, T. Watts, and C. Stanculescu A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women J. Clin. Psychopharmacol. 65 2004 1601 1606
135. K.J. Ressler, B.O. Rothbaum, L. Tannenbaum, P. Anderson, K. Graap, E. Zimand, L. Hodges, and M. Davis Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear Arch. Gen. Psychiat. 61 2004 1136 1144
136. K.J. Ressler, K.B. Mercer, B. Bradley, T. Jovanovic, A. Mahan, K. Kerley, S.D. Norrholm, V. Kilaru, A.K. Smith, A.J. Myers, M. Ramirez, A. Engel, S.E. Hammack, D. Toufexis, K.M. Braas, E.B. Binder, and V. May Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor Nature 470 2011 492 497
137. J.M. Reul, and D.J. Nutt Glutamate and cortisol - a critical confluence in PTSD? J. Psychopharmacol. 22 2008 469 472
138. J.M. Reul, M.S. Labeur, D.E. Grigoriadis, E.B. De Souza, and F. Holsboer Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide Neuroendocrinology 60 1994 509 519
139. L.R. Reznikov, C.A. Grillo, G.G. Piroli, R.K. Pasumarthi, L.P. Reagan, and J. Fadel Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment Eur. J. Neurosci. 25 2007 3109 3114
140. B. Roozendaal, K.L. Brunson, B.L. Holloway, J.L. McGaugh, and T.Z. Baram Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation Proc. Natl. Acad. Sci. U S A 99 21 2002 13908 13913
141. B. Roozendaal, G. Schelling, and J.L. McGaugh Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the {beta}-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation J. Neurosci. 28 2008 6642 6651
142. B. Roozendaal 1999 Curt P. Richter award: glucocorticoids and the regulation of memory consolidation Psychoneuroendocrinology 25 2000 213 238
143. B. Roozendaal, G.L. Quirarte, and J.L. McGaugh Glucocorticoids interact with the basolateral amygdala beta-adrenoceptor-cAMP/PKA system in influencing memory consolidation Eur. J. Neurosci. 15 2002 553 560
144. G. Saxe, F. Stoddard, D. Courtney, K. Cunningham, N. Chawla, R. Sheridan, D. King, and L. King Relationship between acute morphine and the course of PTSD in children with burns J. Am. Acad. Child. Adolesc. Psychiat. 40 2001 915 921
145. G. Schelling, J. Briegel, B. Roozendaal, C. Stoll, H.B. Rothenhausler, and H.P. Kapfhammer The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder survivors Biol. Psychiat. 50 2001 978 985
146. G. Schelling, E. Kilger, B. Roozendaal, D.J. de Quervain, J. Briegel, A. Dagge, H.B. Rothenhäusler, T. Krauseneck, G. Nollert, and H.P. Kapfhammer Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study Biol. Psychiat. 55 2004 627 633
147. + channel-mediated release Neuropharmacology 53 2007 854 862
148. S.M. Southwick, J.H. Krystal, J.D. Bremner, C.A. Morgan III, A.L. Nicolaou, L.M. Nagy, D.R. Johnson, G.R. Heninger, and D.S. Charney Noradrenergic and serotonergic function in posttraumatic stress disorder Arch. Gen. Psychiatry 54 1997 749 758
149. S.M. Southwick, J.D. Bremner, A. Rasmusson, C.A. Morgan 3rd, A. Arnsten, and D.S. Charney Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder Biol. Psychiat. 46 1999 1192 1204
150. S.M. Southwick, C.A. Morgan III, D.S. Charney, and J.R. High Yohimbine use in a natural setting: effects on posttraumatic stress disorder Biol. Psychiatry 46 1999 442 444
151. M.B. Stein, N.A. Klein, and J.L. Matloff Adjunctive olanzapine for SRI-resistant combat-related PTSD: a double-blind, placebo-controlled study Am. J. Psychiat. 159 2002 1777 1779
152. M.B. Stein, C. Kerridge, J.E. Dimsdale, and D.B. Hoyt Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients J. Trauma Stress 20 2007 923 932
153. S.C. Stout, M.J. Owens, and C.B. Nemeroff Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary- adrenal axis activity by stress and chronic antidepressant treatment J. Pharmacol. Exp. Ther. 300 2002 1085 1092
154. A. Suris, C. North, B. Adinoff, C.M. Powell, and R. Greene Effects of exogenous glucocorticoid on combat-related PTSD symptoms Ann. Clin. Psychiatry 22 4 2010 274 279
155. A. Suzuki, S.A. Josselyn, P.W. Frankland, S. Masushige, A.J. Silva, and S. Kida memory reconsolidation and extinction have distinct temporal biochemical signatures J. Neurosci. 24 2004 4787 4795
156. M. Szymanska, B. Budziszewska, L. Jaworska-Feil, A. Basta-Kaim, M. Kubera, M. Leśkiewicz, M. Regulska, and W. Lason The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats Psychoneuroendocrinol. 34 2009 822 832
157. S.M. Taubenfeld, J.S. Riceberg, A.S. New, and C.M. Alberini Preclinical assessment for selectively disrupting a traumatic memory via postretrieval inhibition of glucocorticoid receptors Biol. Psychiat. 65 2009 249 257
158. F.B. Taylor, P. Martin, C. Thompson, J. Williams, T.A. Mellman, C. Gross, E.R. Peskind, and M.A. Raskind Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study Biol. Psychiatry 63 2008 629 632
159. M.S. Tollenaar, B.M. Elzinga, P. Spinhoven, and W. Everaerd Psychophysiological responding to emotional memories in healthy young men after cortisol and propranolol administration Psychopharmacology 203 2009 793 803
160. S. Tronel, and C.M. Alberini Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala Biol. Psychiat. 62 2007 33 39
161. B.A. Van der Kolk, D. Dreyfuss, M. Michaels, D. Shera, R. Berkowitz, R. Fisler, and G. Saxe Fluoxetine in posttraumatic stress disorder J. Clin. Psychiatry 55 1994 517 522
162. D.L. Walker, and M. Davis Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer Brain Struct. Funct. 213 2008 29 42
163. D.L. Walker, K.J. Ressler, K.T. Lu, and M. Davis Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats J. Neurosci. 22 2002 2343 2351
164. H.N. Wang, Y. Peng, Q.R. Tan, Y.C. Chen, R.G. Zhang, Y.T. Qiao, H.H. Wang, L. Liu, F. Kuang, B.R. Wang, and Z.J. Zhang Quetiapine ameliorates anxiety-like behavior and cognitive impairments in stressed rats: implications for the treatment of posttraumatic stress disorder Physiol. Res. 59 2010 263 271
165. F. Weis, E. Kilger, B. Roozendaal, D.J. de Quervain, P. Lamm, M. Schmidt, M. Schmölz, J. Briegel, and G. Schelling Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study J. Thorac. Cardiovasc. Surg. 131 2006 277 282
166. P. Xie, H.R. Kranzler, J. Poling, M.B. Stein, R.F. Anton, K. Brady, R.D. Weiss, L. Farrer, and J. Gelernter Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations Arch. Gen Psychiatry 66 2009 1201 1209
167. H. Xu, Z. Chen, J. He, S. Haimanot, X. Li, L. Dyck, and X.M. Li Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus Hippocampus 16 2006 551 559
168. S. Yamamoto, S. Morinobu, M. Fuchikami, A. Kurata, T. Kozuru, and S. Yamawaki Effects of single prolonged stress and d-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD Neuropsychopharmacology 33 2008 2108 2116
169. S. Yamamura, M. Abe, M. Nakagawa, S. Ochi, S.-I. Ueno, and M. Okada Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions Neuropharmacology 60 4 2011 550 560
170. R. Yehuda Risk and resilience in posttraumatic stress disorder J. Clin. Psychiat. 65 2004 29 36
171. R. Yehuda Neuroendocrine aspects of PTSD T. Steckler, N.H. Kalin, J.M.H.M. Reul, Handbook of Stress and the Brain, Part 2 2005 Elsevier Amsterdam 251 272
172. S. Zhang, and J. Cranney The role of GABA and anxiety in the reconsolidation of conditioned fear Behav. Neurosci. 122 2008 1295 1305
173. J. Zohar, D. Amital, C. Miodownik, M. Kotler, A. Bleich, R.M. Lane, and C. Austin Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder J. Clin. Psychopharm. 22 2002 190 195
174. K. Zushida, M. Sakurai, K. Wada, and M. Sekiguchi Facilitation of extinction learning for contextual fear memory by PEPA: a potentiator of AMPA receptors J. Neurosci. 27 2007 158 166